Department Of Medicine 16
751. Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
752. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
753. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
754. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
755. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
756. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
757. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
758. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
759. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
760. Global Surgery and Health Equity: Integrating Education, Research, and Policy—A Perspective Review
761. The Evolving Role of Palliative Care in Older People with Glioblastoma
762. The Evolving Role of Palliative Care in Older People with Glioblastoma
763. Assessing the impact of screening, early identification and intervention programmes for chronic kidney disease: Protocol for a scoping review
764. Assessing the impact of screening, early identification and intervention programmes for chronic kidney disease: Protocol for a scoping review
765. Assessing the impact of screening, early identification and intervention programmes for chronic kidney disease: Protocol for a scoping review
766. Assessing the impact of screening, early identification and intervention programmes for chronic kidney disease: Protocol for a scoping review
767. Assessing the impact of screening, early identification and intervention programmes for chronic kidney disease: Protocol for a scoping review
768. Early Identification of CKD—A Scoping Review of the Global Populations
769. Early Identification of CKD—A Scoping Review of the Global Populations
770. Early Identification of CKD—A Scoping Review of the Global Populations
771. Early Identification of CKD—A Scoping Review of the Global Populations
772. Early Identification of CKD—A Scoping Review of the Global Populations
773. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
774. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
775. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
776. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
777. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
778. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
779. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
780. Prevalence of Impaired Fasting Glucose and Type 2 Diabetes in Kazakhstan: Findings From Large Study
781. Recapping the Features of SARS-CoV-2 and Its Main Variants: Status and Future Paths
782. A case of pediatric perioperative anaphylaxis to neuromuscular agents and its management
783. Patient-Reported Outcomes Among Patients Pre– and Post–Left Ventricular Assist Device Implantation: A Retrospective and Comparative Study
784. Concomitant Surgical Procedures and Aspirin Avoidance With Left Ventricular Assist Device Therapy
785. Magnitude and determinants of excess total, age-specific and sex-specific all-cause mortality in 24 countries worldwide during 2020 and 2021: results on the impact of the COVID-19 pandemic from the CMOR project
786. Magnitude and determinants of excess total, age-specific and sex-specific all-cause mortality in 24 countries worldwide during 2020 and 2021: results on the impact of the COVID-19 pandemic from the CMOR project
787. Retraction Note: The randomized clinical trial results of the anxiety treatment in patients with somatoform dysfunction and neurotic disorders (Sci Rep, (2021), 11, (24282), 10.1038/s41598-021-03727-5)
788. The randomized clinical trial results of the anxiety treatment in patients with somatoform dysfunction and neurotic disorders
789. Nonpharmaceutical interventions reduce the incidence and mortality of COVID-19: A study based on the survey from the International COVID-19 Research Network (ICRN)
790. Patients receiving hemodialysis do not lose SARS-CoV-2 antibodies more rapidly than non-renal controls: a prospective cohort study
791. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
792. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
793. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
794. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
795. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
796. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
797. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
798. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
799. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
800. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
1 14 15 16 17 18 24